Castle Creek Arbitrage’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Castle Creek Arbitrage’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-25,045	Closed	-$43K	–	102
2015 Q2	$43K	Sell	25,045 -38,900	-61%	-$66.8K	﹤0.01%	89
2015 Q1	$89K	Hold	63,945	–	–	﹤0.01%	78
2014 Q4	$97K	Hold	63,945	–	–	﹤0.01%	82
2014 Q3	$132K	Hold	63,945	–	–	0.01%	76
2014 Q2	$196K	Hold	63,945	–	–	0.01%	85
2014 Q1	$160K	Buy	+63,945	New	+$160K	0.01%	93

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Castle Creek Arbitrage's RXII Position: Q3 2015 in Review

Castle Creek Arbitrage sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 25,045 shares — an estimated $43K sold.

Castle Creek Arbitrage first reported a position in RXII in Q1 2014 and held it in 6 quarters. The position peaked at $196K in Q2 2014. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

Castle Creek Arbitrage reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
Castle Creek Arbitrage sold 25,045 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $43K.
Castle Creek Arbitrage first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 6 quarters.
Castle Creek Arbitrage's GALENA BIOPHARMA INC COM position peaked at $196K in Q2 2014.
78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Castle Creek Arbitrage's 13F filing for Q3 2015, filed 16 Nov 2015.